Cierra N. Sharp

Cierra N. Sharp

Aug 15, 2016

Group 6 Copy 43
-3
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    An initial exploration of in-situ underwater genetic sequencing

    Our goal is to adapt portable genome sequencing technology for high-pressure, underwater environments. Currently...

    Health impacts of plastic on inshore fish in the Florida Keys

    Tiny pieces of plastic (microplastics), have been found at the highest camp on Mt. Everest (26,000 ft up...

    Can fungi help restore the American chestnut?

    Mycorrhizae are fungi that live in the soil and form partnerships with plants, providing hard-to-find nutrients...

    Backer Badge Funded